Executive Summary: Middle East and Africa Omega 3 Market

Market Scope: Comprehensive market analysis of the Middle East and Africa (MEA) omega-3 industry covering product types, application sectors, marine/plant sources, and regional/country-level dynamics.
Market Valuation: Valued at USD 357.12 million (2025), estimated at USD 397.47 million (2026), and projected to reach USD 935.98 million by 2034, growing at a robust CAGR of 11.3% (2026–2034).
Primary Growth Drivers: Surging demand for DHA-enriched infant formula to support early childhood brain development, rising consumer healthcare awareness regarding chronic diseases, and increased penetration of omega-3 in active pharmaceutical ingredients (APIs).

Key Market Segment Metrics (2026–2034)

Category	Leading Segment (2025 Position)	Fastest-Growing Segment
By Type	Docosahexaenoic Acid (DHA) (dominant share driven by infant formula and cognitive health applications)	EPA & DHA multi-blends
By Application	Dietary Supplements & Functional Foods (holding major consumption shares due to preventative health trends)	Infant Formula & Pharmaceutical APIs
By Source	Marine Sources (fish oil, krill oil, and algal sources capturing the vast majority of production volume)	Plant-Derived Sources (chia, flaxseed, and specialized vegan oils)
By Region / Country	GCC Countries (KSA, UAE) & South Africa (accounting for the highest regional adoption rates and market revenues)	Rest of MEA emerging markets and North African hubs (Egypt)

Major Market Players & Market Structure

Market Structure: Highly consolidated among major global specialty ingredient and chemical life science corporations, with competition centered on purity standards, high-concentration EPA/DHA extraction technologies, and regulatory compliance.

Key Companies: Aker BioMarine, GC Rieber Oils AS, Lonza, Axellus, BASF SE, DSM, Omega Protein Corporation, Luhua Biomarine (Shandong) Co., Ltd., Croda International Plc, and FMC Corporation.

Middle East and Africa Omega 3 Market Size

The Middle East and Africa omega 3 market size was valued at USD 357.12 million in 2025 and is projected to reach USD 935.98 million by 2034 from USD 397.47 million in 2026, growing at a CAGR of 11.3%.

Since omega-3 has become increasingly popular in other applications, several works is underway to determine the effects of omega-3 on the health of babies and children. It was found to be related to positive cognitive results in childhood intake of DHA-rich formula in infantile years. For boys, the bulk of brain development takes place during gestation and the first two years of life.

Babies need DHA and ARA during this time. Such nutrients are largely responsible for brain development, which is the main reason why omega-3 infant food products are being increased. As the number of workers in a household, including women, rises, parents find it difficult to track their children's health continuously. This has turned your attention to synthesis. The industry is driven by the increasing penetration of omega3 in the API market. This is in response to increased understanding of health care and chronic diseases, expanded scope of drug use and legislation that promote the use of drugs in formulations for children.

MARKET SEGMENTATION

This research report on the Middle East and Africa omega 3 market has been segmented and sub-segmented into the following categories.

By Type

By Application

Dietary Supplements
Functional Foods & Beverages
Pharmaceuticals
Infant Formula

By Source

Marine
Plant

By Country

KSA
UAE
Israel
rest of GCC countries
South Africa
Ethiopia
Kenya
Egypt
Sudan
rest of MEA

KEY MARKET PLAYERS

The major key players in the Middle East and Africa Omega 3 market are Aker BioMarine, GC Rieber Oils AS, Lonza, Axellus, BASF SE, DSM, Omega Protein Corporation, Luhua Biomarine (Shandong) Co., Ltd., Croda International Plc, FMC Corporation, and others.

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Middle East and Africa Omega 3 Market Report